Daisuke Tanaka

Background

About Daisuke Tanaka

2020 - Present: Cytiva (Global Life Sciences Technologies Japan) Business development and contract to install new equipment, facility and system for biopharmaceutical manufacturing (monoclonal antibody, fusion protein, mRNA, AAV, human cell, etc.) to Japanese Pharma and CDMO clients. Bridge manufacturing support such as process development, chromatography resin screening, filter validation, GMP batch manufacturing for early clinical. 2015 - 2020 : Catalent Pharma Solutions Business development in contract manufacturing service of Drug Product and Drug Substance, especially biologics (monoclonal antibody, recombinant protein, vaccine, peptide, nucleotide). 2010 - 2015 : Lonza Business development in contract manufacturing service of chemical drug substance (small molecule, highly potent compound, peptide, ADC, etc.). 1996 - 2010 : Kaneka Corporation - New business development of chromatography resin for biologics manufacturing process in Kaneka- New business development of fine chemical product for pharmaceutical API in Kaneka- Experience to work in Kaneka America Corporation in NY city for 2 years. Business travel to various countries (US, UK, Switzerland, Germany, France, Denmark, Austria, Hungary, Holland, Italy, Belgium, Spain, South Korea, Taiwan, Hong Kong, China, etc. in whole business life.